[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"law-eurlex-reg_2017_171-de":3},{"abbreviation":4,"title":5,"source_type":6,"total":7,"offset":8,"entries":9},"reg_2017_171","zur Änderung der Anhänge II, III und IV der Verordnung (EG) Nr. 396\u002F2005 des Europäischen Parlaments und des Rates hinsichtlich der Rückstandshöchstgehalte für Aminopyralid, Azoxystrobin, Cyantraniliprol, Cyflufenamid, Cyproconazol, Diethofencarb, Dithiocarbamate, Fluazifop-P, Fluopyram, Haloxyfop, Isofetamid, Metalaxyl, Prohexadion, Propaquizafop, Pyrimethanil, Trichoderma atroviride Stamm SC1 und Zoxamid in oder auf bestimmten Erzeugnissen","eurlex",17,0,[10,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60],{"norm_key":11,"title":12,"chapter":13,"slug":14},"ErwGr. 1",null,"Erwägungsgründe","erwgr-1",{"norm_key":16,"title":12,"chapter":13,"slug":17},"ErwGr. 2","erwgr-2",{"norm_key":19,"title":12,"chapter":13,"slug":20},"ErwGr. 3","erwgr-3",{"norm_key":22,"title":12,"chapter":13,"slug":23},"ErwGr. 4","erwgr-4",{"norm_key":25,"title":12,"chapter":13,"slug":26},"ErwGr. 5","erwgr-5",{"norm_key":28,"title":12,"chapter":13,"slug":29},"ErwGr. 6","erwgr-6",{"norm_key":31,"title":12,"chapter":13,"slug":32},"ErwGr. 7","erwgr-7",{"norm_key":34,"title":12,"chapter":13,"slug":35},"ErwGr. 8","erwgr-8",{"norm_key":37,"title":12,"chapter":13,"slug":38},"ErwGr. 9","erwgr-9",{"norm_key":40,"title":12,"chapter":13,"slug":41},"ErwGr. 10","erwgr-10",{"norm_key":43,"title":12,"chapter":13,"slug":44},"ErwGr. 11","erwgr-11",{"norm_key":46,"title":12,"chapter":13,"slug":47},"ErwGr. 12","erwgr-12",{"norm_key":49,"title":12,"chapter":13,"slug":50},"ErwGr. 13","erwgr-13",{"norm_key":52,"title":12,"chapter":13,"slug":53},"ErwGr. 14","erwgr-14",{"norm_key":55,"title":12,"chapter":12,"slug":56},"Art. 1","art-1",{"norm_key":58,"title":12,"chapter":12,"slug":59},"Art. 2","art-2",{"norm_key":61,"title":12,"chapter":62,"slug":12},"Anhang","Anhänge"]